Steve Young
Chief Tech/Sci/R&D Officer chez ARCUS BIOSCIENCES, INC.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Juan Jaen | M | 66 |
Flexus Biosciences, Inc.
 Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | 22 ans |
| William Rieflin | M | 64 |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA.
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 18 ans |
| Terry Rosen | M | 65 |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | 20 ans |
| Robert Bradway | M | 61 | 18 ans | |
| Andrew J. Perlman | M | 76 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 16 ans |
| David Lacey | M | 71 | 22 ans | |
| Jennifer Jarrett | F | 53 | 7 ans | |
| Robert Goeltz | M | 51 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 7 ans |
| Brian Wong | M | 52 | 9 ans | |
| Clarence Machado | M | 60 | 5 ans | |
| Alexander Azoy | M | 48 | 4 ans | |
| Esteban Santos | M | 56 | 17 ans | |
| Nicole Lambert | F | 50 | 3 ans | |
| David Reese | M | 61 | 19 ans | |
| Matthew Busch | M | 50 | 20 ans | |
| Antoni Ribas | M | 57 | 5 ans | |
| Kathryn Falberg | F | 63 | 7 ans | |
| Tyler Jacks | M | 63 | 12 ans | |
| Andrew Nix | M | - |
University of Bristol
| 35 ans |
| Yasunori Kaneko | M | 69 | 9 ans | |
| Ronald Sugar | M | 75 | 14 ans | |
| Holli Kolkey | M | - | - | |
| Rachna Khosla | F | - | 11 ans | |
| Eric Matthews | M | - | 5 ans | |
| Dimitry Nuyten | M | - | 2 ans | |
| Yvonne Gehring | F | - | 8 ans | |
| Carolyn Tang | F | 45 | 7 ans | |
| Johanna Mercier | F | 54 | - | |
| Merdad Parsey | M | 61 | 4 ans | |
| Jonathan Yingling | M | 55 | 4 ans | |
| Linda Higgins | M | 62 | 3 ans | |
| William Ho | M | 58 | 9 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| David W. Beier | M | 75 | 10 ans | |
| David Goeddel | M | 72 |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | 8 ans |
| Pamela Wapnick | F | 58 | 9 ans | |
| Jason Barker | M | 54 | 1 ans | |
| Paul Eisenberg | M | - | 14 ans | |
| Kevin Sharer | M | 76 | 20 ans | |
| Dennis Fenton | M | 72 | 27 ans | |
| Marc M. P. de Garidel | M | 66 | 15 ans | |
| Steven McKnight | M | 75 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 13 ans |
| Gregory L. Tewalt | M | - | - | |
| Vasant Prakash Gandhi | M | - | 5 ans | |
| Craig Shepherd | M | - | 7 ans | |
| Cynthia Patton | F | 62 | 15 ans | |
| Raymond C. Jordan | M | 70 | 7 ans | |
| Diana McKenzie | F | 59 | 12 ans | |
| John Moriarty | M | 56 | 6 ans | |
| Thomas Zindrick | M | 65 | 8 ans | |
| Marco Renoldi | M | 67 | 3 ans | |
| Michael Severino | M | 58 | 10 ans | |
| Rekha Hemrajani | F | 54 | - | |
| Preston Klassen | M | 55 | 7 ans | |
| Annette L. Such | F | 55 | - | |
| Yi Ning Zhao | M | 53 | 9 ans | |
| Laurie Stelzer | F | 56 | 2 ans | |
| Robert Azelby | M | 56 | 5 ans | |
| Joseph Newell | M | 54 | 7 ans | |
| Susan Lundeen Smuck | F | 57 | 12 ans | |
| Andreas Grauer | M | 63 | - | |
| Melissa C. Paoloni | M | - | 4 ans | |
| Michael Quigley | M | 42 | - | |
| Nathan Hardy | M | 48 | 10 ans | |
| Rachel Lenington | F | 51 | 10 ans | |
| Carla Daniel | F | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 6 ans |
| Sean B. W. Martin | M | 61 | - | |
| Leonard Schaeffer | M | 78 | 9 ans | |
| James Daly | M | 63 | 9 ans | |
| Stuart Green | M | 58 |
University of Bristol
| 6 ans |
| David J. Scott | M | 71 | - | |
| Rebecca M. Henderson | M | 63 | 11 ans | |
| Timothy Martin | M | 55 | 3 ans | |
| Kristen Hege | M | 60 | 1 ans | |
| Dominique Monnet | M | 65 | 11 ans | |
| Frank Herringer | M | 81 | 15 ans | |
| Vance D. Coffman | M | 79 | 9 ans | |
| Frederick Gluck | M | 88 | 13 ans | |
| Pieter B. M. W. M. Timmermans | M | 74 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 8 ans |
| Patricia Cary Sueltz | F | 71 | 2 ans | |
| George Morrow | M | 72 | 10 ans | |
| J. Reason | M | 83 | 12 ans | |
| Thomas Johannes W. Dittrich | M | 60 | 4 ans | |
| Jin Long Chen | M | 61 | 4 ans | |
| William Ashton | M | 73 | 16 ans | |
| William P. Sheridan | M | 69 | 5 ans | |
| Cynthia Flowers | F | 64 | 5 ans | |
| Laura Fletcher | M | - |
University of Bristol
| 7 ans |
| François de Carbonnel | M | 78 | 10 ans | |
| Yujiro Hata | M | 49 |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | 1 ans |
| John Smither | M | 71 | 6 ans | |
| Steven Galson | M | 67 | - | |
| Michael Castagna | M | 47 | 4 ans | |
| Bradley J. Maroni | M | 71 | 6 ans | |
| Stephen Blackwood | M | 61 | 7 ans | |
| Urte Gayko | M | 53 | 9 ans | |
| Lauren Lee | M | - | 2 ans | |
| Kevin L. Stark | M | - | 15 ans | |
| Beth Seidenberg | M | 67 | 3 ans | |
| Jude Dinges | M | - | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 96 | 96,97% |
| Royaume-Uni | 3 | 3,03% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Steve Young
- Réseau Personnel
